Literature DB >> 2173763

Role of macrophages in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice.

H S Baek1, J W Yoon.   

Abstract

Pancreatic islets from SJL/J mice infected with the D variant of encephalomyocarditis virus (EMC-D virus) showed lymphocytic infiltration with moderate to severe destruction of beta cells. Immunohistochemical staining of the islet sections with several monoclonal antibodies, anti-Mac-1, anti-Mac-2, and F4/80 for macrophages, anti-L3T4 for helper/inducer T cells, and anti-Lyt2 for cytotoxic/suppressor T cells revealed that the major population of infiltrating cells at the early stage of viral infection was Mac-2-positive macrophages. In contrast, macrophages detected by anti-Mac-1 and F4/80 monoclonal antibodies were not found at the early stage of viral infection but were found at intermediate and late stages of viral infection. Helper/inducer T cells and cytotoxic/suppressor T cells also infiltrated the islets at intermediate and late stages of viral infection. Short-term treatment of mice with silica prior to viral infection resulted in an enhancement of beta-cell destruction, leading to the development of diabetes. In contrast, long-term treatment of mice with silica resulted in complete prevention of diabetes caused by a low dose of viral infection and a significant decrease in the incidence of diabetes caused by an intermediate or high dose of viral infection. Furthermore, depletion of macrophages by a specific monoclonal antibody (anti-Mac-2) resulted in a much greater decrease in the incidence of diabetes caused by an intermediate dose of viral infection. However, suppression of helper/inducer T cells and cytotoxic/suppressor T cells, by anti-L3T4 and anti-Lyt2 antibodies, respectively, did not alter the incidence of diabetes. On the basis of these data, it is concluded that macrophages, particularly Mac-2-positive macrophages, play a crucial role in the process of pancreatic beta-cell destruction at the early stage of encephalomyocarditis D virus infection in SJL/J mice.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173763      PMCID: PMC248710          DOI: 10.1128/JVI.64.12.5708-5715.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

Review 1.  The role of viruses in the pathogenesis of pancreatic disease and diabetes mellitus.

Authors:  J E Craighead
Journal:  Prog Med Virol       Date:  1975

2.  Virus-induced diabetes mellitus: VIII. Passage of encephalomyocarditis virus and severity of diabetes in susceptible and resistant strains of mice.

Authors:  J Yoon; T Onodera; A L Notkins
Journal:  J Gen Virol       Date:  1977-11       Impact factor: 3.891

3.  Genetic differences in susceptibility of pancreatic beta cells to virus-induced diabetes mellitus.

Authors:  J W Yoon; M A Lesniak; R Fussganger; A L Notkins
Journal:  Nature       Date:  1976-11-11       Impact factor: 49.962

4.  Evidence for a single locus controlling susceptibility to virus-induced diabetes mellitus.

Authors:  T Onodera; J W Yoon; K S Brown; A L Notkina
Journal:  Nature       Date:  1978-08-17       Impact factor: 49.962

5.  Isolation of a virus from the pancreas of a child with diabetic ketoacidosis.

Authors:  J W Yoon; M Austin; T Onodera; A L Notkins
Journal:  N Engl J Med       Date:  1979-05-24       Impact factor: 91.245

6.  Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice.

Authors:  T Koike; Y Itoh; T Ishii; I Ito; K Takabayashi; N Maruyama; H Tomioka; S Yoshida
Journal:  Diabetes       Date:  1987-04       Impact factor: 9.461

7.  Spontaneous diabetes mellitus: reversal and prevention in the BB/W rat with antiserum to rat lymphocytes.

Authors:  A A Like; A A Rossini; D L Guberski; M C Appel; R M Williams
Journal:  Science       Date:  1979-12-21       Impact factor: 47.728

8.  The inability of a diabetogenic virus to induce diabetes mellitus in athymic (nude) mice.

Authors:  K Buschard; J Rygaard; E Lung
Journal:  Acta Pathol Microbiol Scand C       Date:  1976-08

9.  Virus-induced diabetes mellitus. VI. Genetically determined host differences in the replicating of encephalomyocarditis virus in pancreatic beta cells.

Authors:  J W Yoon; A L Notkins
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

10.  Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus.

Authors:  J W Yoon; P R McClintock; T Onodera; A L Notkins
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  15 in total

1.  Mengovirus and encephalomyocarditis virus poly(C) tract lengths can affect virus growth in murine cell culture.

Authors:  L R Martin; Z C Neal; M S McBride; A C Palmenberg
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Distribution of viral RNA in the spinal cord of DBA/2 mice developing biphasic paralysis following infection with the D variant of encephalomyocarditis virus (EMC-D).

Authors:  M Takeda; R Miura; K Shiota; K Hirasawa; M J Lee; S I Itagaki; K Doi
Journal:  Int J Exp Pathol       Date:  1995-12       Impact factor: 1.925

3.  CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo.

Authors:  Petr O Ilyinskii; Ruojie Wang; Steven P Balk; Mark A Exley
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Role of Hck in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice.

Authors:  K S Choi; H S Jun; H N Kim; H J Park; Y W Eom; H L Noh; H Kwon; H M Kim; J W Yoon
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  In vivo administration of serum thymic factor (FTS) prevents EMC-D virus-induced diabetes and myocarditis in BALB/cAJcl mice.

Authors:  M Mizutani; M El-Fotoh; M Mori; K Ono; K Doi; A Awaya; Y Matsumoto; Y Matsumoto; T Onodera
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 6.  The immunologic insult in type 1 diabetes.

Authors:  M C Honeyman; L C Harrison
Journal:  Springer Semin Immunopathol       Date:  1993

7.  WIN 54954 treatment of mice infected with a diabetogenic strain of group B coxsackievirus.

Authors:  D M See; J G Tilles
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

8.  Biphasic disease of central nervous system induced in DBA/2 mice by the D variant of encephalomyocarditis virus (EMC-D).

Authors:  M Takeda; S Itagaki; K Doi
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

9.  Role of nitric oxide in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice.

Authors:  Young-Sun Lee; Na Li; Seungjin Shin; Hee-Sook Jun
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

10.  Innate immune response to encephalomyocarditis virus infection mediated by CD1d.

Authors:  Mark A Exley; Nancy J Bigley; Olivia Cheng; Angela Shaulov; Syed Muhammad Ali Tahir; Quincy L Carter; Jorge Garcia; Carren Wang; Kurt Patten; Harold F Stills; Frederick W Alt; Scott B Snapper; Steven P Balk
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.